Fifth Third Bancorp
ANAC

Fifth Third Bancorp’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Fifth Third Bancorp’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,526
Closed -$82K – 2477
2016
Q1 		$82K Buy
1,526
+296
+24% +$21.9K ﹤0.01% 1164
2015
Q4 		$139K Buy
1,230
+1,202
+4,293% +$132K ﹤0.01% 1055
2015
Q3 		$3K Buy
+28
New +$3.66K ﹤0.01% 2569

Other funds holding ANAC

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Fifth Third Bancorp's ANAC Position: Q2 2016 in Review

Fifth Third Bancorp sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 1,526 shares — an estimated $82K sold.

Fifth Third Bancorp first reported a position in ANAC in Q3 2015 and held it in 3 quarters. The position peaked at $139K in Q4 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • Fifth Third Bancorp reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • Fifth Third Bancorp sold 1,526 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $82K.
  • Fifth Third Bancorp first reported a position in ANACOR PHARMACEUTICALS INC COM in Q3 2015 and held it in 3 quarters.
  • Fifth Third Bancorp's ANACOR PHARMACEUTICALS INC COM position peaked at $139K in Q4 2015.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Fifth Third Bancorp's 13F filing for Q2 2016, filed 11 Aug 2016.